Richard Edelman - Merit Medical Independent Director
| MMSI Stock | USD 73.78 0.40 0.55% |
Director
Mr. Richard W. Edelman is an Independent Director of Merit Medical Systems, Inc., since 1988. Mr. Edelman was principally engaged in the management of private investments since February 2013. From April 2011 through February 2013, Mr. Edelman was engaged as an independent representative of SWS Financial Services, Inc., a registered investment advisor and registered brokerdealer. From 2000 through April of 2011, Mr. Edelman was a Managing Director and Senior Vice President of SMH Capital Inc., an investment banking firm . From 2000 to 2006, he was the Managing Director and Manager of SMH Dallas branch. From 1998 to 2000, he was a Senior Vice President and Branch Manager of Southwest Securities, Inc., a stock brokerage firm headquartered in Dallas, Texas. From 1996 to 1998, he was a Vice President of Rodman Renshaw, Inc., a stock brokerage firm. From 1987 to 1996, he was employed by Southwest Securities, Inc. as a Senior Vice President and securities analyst. Prior to joining Southwest Securities, Inc., Mr. Edelman was a securities analyst and Vice President for Schneider, Bernet and Hickman, a Dallas, Texas securities firm. Mr. Edelman obtained a MBA degree from Columbia University in 1966. Mr. Edelman serves as a director, in part, because of the depth of his financial training, experience and his analytical acumen. Mr. Edelman possesses a keen ability to review and understand financial information, both with respect to the Company and with respect to potential business partners and acquisition candidates. His financial training and experience have been extremely valuable to the Board in his service on the Audit Committee and his qualification as an audit committee financial expert. As the Lead Independent Director, Mr. Edelman has demonstrated his ability to ask difficult questions and encourage the Company implementation of strong financial practices. since 1988.
| Age | 73 |
| Tenure | 36 years |
| Address | 1600 West Merit Parkway, South Jordan, UT, United States, 84095 |
| Phone | 801 253 1600 |
| Web | https://www.merit.com |
Merit Medical Management Efficiency
The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0805 %, meaning that it created $0.0805 on every $100 dollars invested by stockholders. Merit Medical's management efficiency ratios could be used to measure how well Merit Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Merit Medical's Return On Capital Employed is increasing as compared to previous years. The Merit Medical's current Return On Assets is estimated to increase to 0.05, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Merit Medical's Total Current Assets are increasing as compared to previous years. The Merit Medical's current Intangible Assets is estimated to increase to about 342.2 M, while Other Assets are projected to decrease to under 25.7 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Carlos Toledo | Alcon AG | N/A | |
| Ignacio Lopez | Alcon AG | N/A | |
| Giovanna Monnas | AptarGroup | 65 | |
| Ronald Taylor | ResMed Inc | 72 | |
| Craig Owens | AptarGroup | 63 | |
| Nicholas Dignam | Alcon AG | N/A | |
| Jesse Wu | AptarGroup | 62 | |
| Thomas Hofmann | West Pharmaceutical Services | 68 | |
| William Feehery | West Pharmaceutical Services | 50 | |
| Paula Cholmondeley | Dentsply Sirona | 66 | |
| Ralf Wunderlich | AptarGroup | 55 | |
| Thomas Jetter | Dentsply Sirona | 60 | |
| Mark Buthman | West Pharmaceutical Services | 60 | |
| Eileen Auen | AngioDynamics | 55 | |
| Robert Swinney | ICU Medical | 72 | |
| John Weiland | West Pharmaceutical Services | 61 | |
| Malcolm Pradhan | Alcon AG | N/A | |
| Myla LaiGoldman | West Pharmaceutical Services | 62 | |
| Paula Johnson | West Pharmaceutical Services | 59 | |
| John Wareham | ResMed Inc | 73 | |
| Joanne Smith | AptarGroup | 59 | |
Management Performance
| Return On Equity | 0.0805 | ||||
| Return On Asset | 0.0399 |
Merit Medical Systems Leadership Team
Elected by the shareholders, the Merit Medical's board of directors comprises two types of representatives: Merit Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merit. The board's role is to monitor Merit Medical's management team and ensure that shareholders' interests are well served. Merit Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merit Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Stillabower, Independent Director | ||
| Franklin Miller, Independent Director | ||
| Bernard Birkett, CFO | ||
| Fred Lampropoulos, Chairman, CEO and Pres | ||
| Joseph Wright, President - International Division | ||
| Jill Anderson, Director | ||
| Neil Peterson, Chief Officer | ||
| Elizabeth Huebner, Director | ||
| Kent Stanger, CFO, Secretary, Treasurer, Director | ||
| AnneMarie Wright, Vice President - Corporate Communications | ||
| Brian Lloyd, Chief Legal Officer, Corporate Secretary | ||
| Raul Parra, Interim CFO | ||
| Justin Lampropoulos, Executive Vice President - Sales, Marketing and Strategy | ||
| Richard Edelman, Independent Director | ||
| F Millner, Independent Director | ||
| CPA Parra, CFO Treasurer | ||
| Sarah Comstock, Vice Communications | ||
| JoAnne Alkire, Executive Strategy | ||
| Ronald Frost, COO | ||
| Thomas Gunderson, Independent Director | ||
| David Liu, Director | ||
| Joseph Pierce, Chief Officer | ||
| Nolan Karras, Independent Director | ||
| Nicole Priest, Chief Officer | ||
| Michel Voigt, Chief Officer | ||
| Scott Anderson, Independent Director | ||
| John Knorpp, Chief Officer | ||
| Jason Treft, Chief Officer | ||
| Ann Millner, Independent Director |
Merit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merit Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0805 | ||||
| Return On Asset | 0.0399 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 4.58 B | ||||
| Shares Outstanding | 58.06 M | ||||
| Shares Owned By Insiders | 2.43 % | ||||
| Shares Owned By Institutions | 97.57 % | ||||
| Number Of Shares Shorted | 2.06 M | ||||
| Price To Earning | 956.67 X |
Merit Medical Investors Sentiment
The influence of Merit Medical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Merit. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Merit Medical's public news can be used to forecast risks associated with an investment in Merit. The trend in average sentiment can be used to explain how an investor holding Merit can time the market purely based on public headlines and social activities around Merit Medical Systems. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Merit Medical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Merit Medical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Merit Medical's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Merit Medical.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Merit Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Merit Medical's short interest history, or implied volatility extrapolated from Merit Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Merit Stock analysis
When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Merit Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.62 | Revenue Per Share 21.832 | Quarterly Revenue Growth 0.106 | Return On Assets 0.0399 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.